Corbus Pharmaceuticals Holding Inc. buy melinda
Start price
07.03.19
/
50%
€162.36
Target price
16.05.19
€186.71
Performance (%)
24.00%
End price
16.05.19
€201.32
Summary
This prediction ended on 16.05.19 with a price of €201.32. The prediction had a final performance of 24.00%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Corbus Pharmaceuticals Holding Inc. | 5.051% | 5.051% | 32248.367% | -4.269% |
iShares Core DAX® | -0.268% | 5.471% | 14.271% | 19.027% |
iShares Nasdaq 100 | 1.854% | 7.851% | 35.426% | 58.415% |
iShares Nikkei 225® | 0.284% | 1.729% | 9.943% | 7.045% |
iShares S&P 500 | 1.178% | 5.269% | 27.989% | 49.400% |
According to melinda what are the pros and cons of Corbus Pharmaceuticals Holding Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Corbus Pharmaceuticals Holdings Inc diskutieren
SecteurRecherche biotechnologique et médicale Agenda 26/03 Publication de résultats
Corbu Pharmaceuticals Holdings, Inc. is Une société au stade de pharmaceutical phase III clinic Qui se le Développement et la CONCENTRE Sur de la commercialisation Nouveaux Traitements verser des maladies rares Traiter et fibrotiques inflammatoires Chroniques et tombes. La Société de SES par des activités le Développement et la commercialisation de Produits Thérapeutiques au treatment de destins maladies fibrotiques rares inflammatoires la vie en mettant danger. Le produit de la principale candidat Société, le Lenabasum, is inflammation Un Nouveau Medicament Pour L'endocannabinoïdes de vive voix de Résoudre endocannabinoïdes-mimétique designed et les Chronique fibrotiques Processus Arrêter. Lenabasum STIMULE la production de Médiateurs Qui versez l agissent Résoudre des pro-lipidiques résolution (MPS) ' l'inflammation et la fibrose en Activant Arrêter les VOIES endogènes. La Société developpé le lenabasum verser Quatre-: la maladies Traiter sclérose systémique, la fibrose kystique, la dermatomyosite diffuse à Prédominance cutanée diffuse et le cutanée lupus érythémateux systémique (LED).
Nombre d'employés
: 47 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Corbus Pharmaceuticals Holding Inc.
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€42.40
12.11.23
12.11.23
-
12.11.24
12.11.24
-
10.12.23
10.12.23
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€48.78
29.09.20
29.09.20
€120.00
04.11.21
04.11.21
-44.65%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€49.71
16.09.20
16.09.20
€90.00
29.09.20
29.09.20
-1.87%
29.09.20
29.09.20
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€228.66
29.08.20
29.08.20
€150.00
16.09.20
16.09.20
-78.26%
16.09.20
16.09.20
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€208.50
21.05.20
21.05.20
€270.00
29.08.20
29.08.20
9.67%
29.08.20
29.08.20
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€192.13
12.03.18
12.03.18
€211.07
12.09.18
12.09.18
-23.94%
12.09.18
12.09.18
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€184.01
20.09.17
20.09.17
€202.95
06.10.17
06.10.17
11.03%
06.10.17
06.10.17
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€204.00
20.09.17
20.09.17
€225.00
06.10.17
06.10.17
11.03%
06.10.17
06.10.17
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€158.30
17.06.17
17.06.17
€189.42
12.07.17
12.07.17
19.66%
12.07.17
12.07.17
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€175.50
17.06.17
17.06.17
€210.00
12.07.17
12.07.17
19.66%
12.07.17
12.07.17
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€174.54
13.05.17
13.05.17
€192.13
25.05.17
25.05.17
3.10%
25.05.17
25.05.17
Could be worthwhile Investment >10% per year
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€78.47
03.08.16
03.08.16
€81.18
08.08.16
08.08.16
3.45%
08.08.16
08.08.16
Could be worthwhile Investment >10% per year